Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome
This study was carried out to evaluate the effects of vitamin D supplementation on the metabolic profiles of insulin-resistant subjects with polycystic ovary syndrome (PCOS). This randomized double-blind, placebo-controlled trial was conducted on 90 insulin-resistant women with PCOS. Participants we...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-11-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/9/12/1280 |
id |
doaj-de7cb7b10ab74758975a891f7b861517 |
---|---|
record_format |
Article |
spelling |
doaj-de7cb7b10ab74758975a891f7b8615172020-11-24T21:00:26ZengMDPI AGNutrients2072-66432017-11-01912128010.3390/nu9121280nu9121280Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary SyndromeMehri Jamilian0Fatemeh Foroozanfard1Elham Rahmani2Maesoomeh Talebi3Fereshteh Bahmani4Zatollah Asemi5Endocrinology and Metabolism Research Center, Arak University of Medical Sciences, Arak 6618634683, IranDepartment of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan 8715988141, IranDepartment of Gynecology and Obstetrics, School of Medicine, Bushehr University of Medical Sciences, Bushehr 7514633341, IranDepartment of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan 8715988141, IranResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan 8715988141, IranResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan 8715988141, IranThis study was carried out to evaluate the effects of vitamin D supplementation on the metabolic profiles of insulin-resistant subjects with polycystic ovary syndrome (PCOS). This randomized double-blind, placebo-controlled trial was conducted on 90 insulin-resistant women with PCOS. Participants were randomly assigned to three groups to intake either 4000 IU of vitamin D or 1000 IU of vitamin D or placebo (n = 30 each group) daily for 12 weeks. Vitamin D supplementation (4000 IU), compared with vitamin D (1000 IU) and placebo, led to significant reductions in total testosterone (−0.2 ± 0.2 vs. −0.1 ± 0.6 and +0.1 ± 0.2 ng/mL, respectively, p = 0.02), free androgen index (FAI) (−0.06 ± 0.12 vs. −0.02 ± 0.12 and +0.004 ± 0.04, respectively, p = 0.04), hirsutism (−1.1 ± 1.1 vs. −0.8 ± 1.2 and −0.1 ± 0.4, respectively, p = 0.001) and high-sensitivity C-reactive protein (hs-CRP) (−0.7 ± 1.4 vs. −0.5 ± 0.9 and +0.5 ± 2.4 mg/L, respectively, p = 0.01). In addition, we found significant elevations in mean change of sex hormone-binding globulin (SHBG) (+19.1 ± 23.0 vs. +4.5 ± 11.0 and +0.7 ± 10.4 nmol/L, respectively, p < 0.001) and total antioxidant capacity (TAC) (+130 ± 144 vs. +33 ± 126 and −36 ± 104 mmol/L, respectively, p < 0.001) in the high-dose vitamin D group compared with low-dose vitamin D and placebo groups. Overall, high-dose vitamin D administration for 12 weeks to insulin-resistant women with PCOS had beneficial effects on total testosterone, SHBG, FAI, serum hs-CRP and plasma TAC levels compared with low-dose vitamin D and placebo groups.https://www.mdpi.com/2072-6643/9/12/1280vitamin D supplementationhormonal profilesinsulin-resistantpolycystic ovary syndrome |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mehri Jamilian Fatemeh Foroozanfard Elham Rahmani Maesoomeh Talebi Fereshteh Bahmani Zatollah Asemi |
spellingShingle |
Mehri Jamilian Fatemeh Foroozanfard Elham Rahmani Maesoomeh Talebi Fereshteh Bahmani Zatollah Asemi Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome Nutrients vitamin D supplementation hormonal profiles insulin-resistant polycystic ovary syndrome |
author_facet |
Mehri Jamilian Fatemeh Foroozanfard Elham Rahmani Maesoomeh Talebi Fereshteh Bahmani Zatollah Asemi |
author_sort |
Mehri Jamilian |
title |
Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome |
title_short |
Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome |
title_full |
Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome |
title_fullStr |
Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome |
title_full_unstemmed |
Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome |
title_sort |
effect of two different doses of vitamin d supplementation on metabolic profiles of insulin-resistant patients with polycystic ovary syndrome |
publisher |
MDPI AG |
series |
Nutrients |
issn |
2072-6643 |
publishDate |
2017-11-01 |
description |
This study was carried out to evaluate the effects of vitamin D supplementation on the metabolic profiles of insulin-resistant subjects with polycystic ovary syndrome (PCOS). This randomized double-blind, placebo-controlled trial was conducted on 90 insulin-resistant women with PCOS. Participants were randomly assigned to three groups to intake either 4000 IU of vitamin D or 1000 IU of vitamin D or placebo (n = 30 each group) daily for 12 weeks. Vitamin D supplementation (4000 IU), compared with vitamin D (1000 IU) and placebo, led to significant reductions in total testosterone (−0.2 ± 0.2 vs. −0.1 ± 0.6 and +0.1 ± 0.2 ng/mL, respectively, p = 0.02), free androgen index (FAI) (−0.06 ± 0.12 vs. −0.02 ± 0.12 and +0.004 ± 0.04, respectively, p = 0.04), hirsutism (−1.1 ± 1.1 vs. −0.8 ± 1.2 and −0.1 ± 0.4, respectively, p = 0.001) and high-sensitivity C-reactive protein (hs-CRP) (−0.7 ± 1.4 vs. −0.5 ± 0.9 and +0.5 ± 2.4 mg/L, respectively, p = 0.01). In addition, we found significant elevations in mean change of sex hormone-binding globulin (SHBG) (+19.1 ± 23.0 vs. +4.5 ± 11.0 and +0.7 ± 10.4 nmol/L, respectively, p < 0.001) and total antioxidant capacity (TAC) (+130 ± 144 vs. +33 ± 126 and −36 ± 104 mmol/L, respectively, p < 0.001) in the high-dose vitamin D group compared with low-dose vitamin D and placebo groups. Overall, high-dose vitamin D administration for 12 weeks to insulin-resistant women with PCOS had beneficial effects on total testosterone, SHBG, FAI, serum hs-CRP and plasma TAC levels compared with low-dose vitamin D and placebo groups. |
topic |
vitamin D supplementation hormonal profiles insulin-resistant polycystic ovary syndrome |
url |
https://www.mdpi.com/2072-6643/9/12/1280 |
work_keys_str_mv |
AT mehrijamilian effectoftwodifferentdosesofvitamindsupplementationonmetabolicprofilesofinsulinresistantpatientswithpolycysticovarysyndrome AT fatemehforoozanfard effectoftwodifferentdosesofvitamindsupplementationonmetabolicprofilesofinsulinresistantpatientswithpolycysticovarysyndrome AT elhamrahmani effectoftwodifferentdosesofvitamindsupplementationonmetabolicprofilesofinsulinresistantpatientswithpolycysticovarysyndrome AT maesoomehtalebi effectoftwodifferentdosesofvitamindsupplementationonmetabolicprofilesofinsulinresistantpatientswithpolycysticovarysyndrome AT fereshtehbahmani effectoftwodifferentdosesofvitamindsupplementationonmetabolicprofilesofinsulinresistantpatientswithpolycysticovarysyndrome AT zatollahasemi effectoftwodifferentdosesofvitamindsupplementationonmetabolicprofilesofinsulinresistantpatientswithpolycysticovarysyndrome |
_version_ |
1716779716353982464 |